Search research articles
Contact Us
Filters
Showing results (111-120 of 125) with videos related to
Page
of 13
Sort By:
Gut
|
August 13, 2025
Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial
Xiang'an Wu, Dongmei Quan, Wei Li, et al.
BMC Cancer
|
July 3, 2014
The role of RhoC in epithelial-to-mesenchymal transition of ovarian carcinoma cells
Wen-feng Gou, Yang Zhao, Hang Lu, et al.
Plos One
|
June 16, 2015
Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer
Jing-lei Qu, Xiu-juan Qu, Zhi Li, et al.
Journal of Translational Medicine
|
April 16, 2021
Association between cigarette smoking and colorectal cancer sidedness: A multi-center big-data platform-based analysis
Lu-Ping Yang, Zi-Xian Wang, Rui Zhang, et al.
Aging
|
January 14, 2020
Integrated transcriptome expression profiling reveals a novel lncRNA associated with L-DOPA-induced dyskinesia in a rat model of Parkinson's disease
Chun-Lei Han, Yun-Peng Liu, Yun-Peng Sui, et al.
Trials
|
March 4, 2024
Effect of Postoperative Prolonged sedation with Dexmedetomidine after successful reperfusion with Endovascular Thrombectomy on long-term prognosis in patients with acute ischemic stroke (PPDET): study protocol for a randomized controlled trial
Li-Na Yang, Yi Sun, Yu-Zhu Wang, et al.
Oncotarget
|
October 7, 2015
S-1 plus cisplatin versus fluorouracil plus cisplatin in advanced gastric or gastro-esophageal junction adenocarcinoma patients: a pilot study
Yu Hong Li, Miao Zhen Qiu, Jian Ming Xu, et al.
Zhonghua Yi Xue Za Zhi
|
February 23, 2007
[Treatment of chemotherapy-induced neutropenia pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase II clinical study]
Yuan-kai Shi, Xiao-hui He, Sheng Yang, et al.
Anti-Cancer Drugs
|
April 11, 2013
Pegylated filgrastim is comparable with filgrastim as support for commonly used chemotherapy regimens: a multicenter, randomized, crossover phase 3 study
Yuan-Kai Shi, Qiang Chen, Yun-Zhong Zhu, et al.
Cancer Cell
|
August 13, 2021
Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study
Qing Zhou, Chong-Rui Xu, Ying Cheng, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 125) with videos related to
Sort By:
Page
of 13
Gut
|
August 13, 2025
Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial
Xiang'an Wu, Dongmei Quan, Wei Li, et al.
BMC Cancer
|
July 3, 2014
The role of RhoC in epithelial-to-mesenchymal transition of ovarian carcinoma cells
Wen-feng Gou, Yang Zhao, Hang Lu, et al.
Plos One
|
June 16, 2015
Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer
Jing-lei Qu, Xiu-juan Qu, Zhi Li, et al.
Journal of Translational Medicine
|
April 16, 2021
Association between cigarette smoking and colorectal cancer sidedness: A multi-center big-data platform-based analysis
Lu-Ping Yang, Zi-Xian Wang, Rui Zhang, et al.
Aging
|
January 14, 2020
Integrated transcriptome expression profiling reveals a novel lncRNA associated with L-DOPA-induced dyskinesia in a rat model of Parkinson's disease
Chun-Lei Han, Yun-Peng Liu, Yun-Peng Sui, et al.
Trials
|
March 4, 2024
Effect of Postoperative Prolonged sedation with Dexmedetomidine after successful reperfusion with Endovascular Thrombectomy on long-term prognosis in patients with acute ischemic stroke (PPDET): study protocol for a randomized controlled trial
Li-Na Yang, Yi Sun, Yu-Zhu Wang, et al.
Oncotarget
|
October 7, 2015
S-1 plus cisplatin versus fluorouracil plus cisplatin in advanced gastric or gastro-esophageal junction adenocarcinoma patients: a pilot study
Yu Hong Li, Miao Zhen Qiu, Jian Ming Xu, et al.
Zhonghua Yi Xue Za Zhi
|
February 23, 2007
[Treatment of chemotherapy-induced neutropenia pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase II clinical study]
Yuan-kai Shi, Xiao-hui He, Sheng Yang, et al.
Anti-Cancer Drugs
|
April 11, 2013
Pegylated filgrastim is comparable with filgrastim as support for commonly used chemotherapy regimens: a multicenter, randomized, crossover phase 3 study
Yuan-Kai Shi, Qiang Chen, Yun-Zhong Zhu, et al.
Cancer Cell
|
August 13, 2021
Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study
Qing Zhou, Chong-Rui Xu, Ying Cheng, et al.
Page
of 13